20273 results for «»
20273 results
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency
04 Nov 2021
Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.
Author
Ludwig T Weckbach
Munich, Germany
Yijun Yao
Sichuan, China
Ou Yuanweixiang
Chengdu, China
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
Daniel Zazueta
CDMX, Mexico
Marco Zuccaro
Bari, Italy
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
PCR London Valves 2021 - Who is doing what?
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis
07 Nov 2021
Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
Amulet IDE: Amplatzer Amulet Left Atrial Appendage Occluder RCT - 12-Month Closure Follow-up
04 Nov 2021
Ali Nazmi Calik reviews Amulet IDE, a prospective, randomized, multi-center and active-control trial designed to compare the Amulet and Watchman 2.5 devices in a head-to-head fashion, and presented by Dhanunjaya Lakkireddy during TCT 2021.
Author
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
GUIDE-HF: can continuous pulmonary artery pressure monitoring improve heart failure management?
09 Nov 2021
The main goal of the randomized GUIDE-HF trial was to assess the ability of continuous PAP monitoring to improve outcomes in patients with heart failure NYHA class II-IV and a HF hospitalization within previous 12 months or elevated BNP/NT-proBNP.
Author
Complications: calcified LM-LAD PCI, CHIP and TAVI
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session on complications to see 3 clinical cases: "calcified LM-LAD PCI with rotablator", "cascading events in a CHIP case" and "complications in TAVI", and discover how they managed to face them.
Best cases and research
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover the best cases and research unveiled at AICT-AsiaPCR 2021: "Positive remodelling of coronary arteries on computed tomography coronary angiogram", "Investigation of heavy metals in coronary artery tissues in autopsy cases", "DEB vs DES in the main vessel for the treatment of...
Wrap-up of the day
08 Oct 2021 – From AICT-AsiaPCR 2021
Imaging in stent thrombosis
09 Oct 2021 – From AsiaPCR 2021
Watch this session to learn more about the importance of intracoronary imaging in stent thrombosis and the role of OCT and IVUS in its evaluation, as well as to discover how imaging helps to identify its mechanism and differentiate it from bystander findings and target specific treatment.
Mechanical circulatory support: which, how, when!
09 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to learn more about the use of mechanical circulatory support in cardiogenic shock and high-risk PCI, the selection of MCS depending on the patient, as well as the strategy of PCI in cardiogenic shock.
